167 related articles for article (PubMed ID: 2423342)
1. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.
Krause W; Krais T
Eur J Clin Pharmacol; 1986; 30(1):61-8. PubMed ID: 2423342
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.
Krause W; Krais T
Eur J Clin Pharmacol; 1987; 32(6):597-605. PubMed ID: 2443364
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of the stable prostacyclin analogue, ZK 36 374, in the cat.
Krause W; Beckmann R; Schubert M
Prostaglandins Leukot Med; 1984 Aug; 15(2):187-97. PubMed ID: 6208562
[TBL] [Abstract][Full Text] [Related]
4. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
Karim SM; Adaikan PG; Lau LC; Tai MY
Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
[TBL] [Abstract][Full Text] [Related]
6. The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers.
Belch JJ; Greer I; McLaren M; Saniabadi AR; Miller S; Sturrock RD; Forbes CD
Prostaglandins; 1984 Jul; 28(1):67-77. PubMed ID: 6207561
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients.
Hildebrand M
Eur J Clin Pharmacol; 1997; 53(1):51-6. PubMed ID: 9349930
[TBL] [Abstract][Full Text] [Related]
8. Hypotension in response to iloprost, a prostacyclin analogue.
Upward JW; Strong HA; George CF; Ogilive BC; Challenor V; Conway N
Br J Clin Pharmacol; 1986 Feb; 21(2):241-3. PubMed ID: 2420348
[No Abstract] [Full Text] [Related]
9. Myocardial ischemia induced by prostacyclin and iloprost.
Bugiardini R; Galvani M; Ferrini D; Gridelli C; Tollemeto D; Mari L; Puddu P; Lenzi S
Clin Pharmacol Ther; 1985 Jul; 38(1):101-8. PubMed ID: 2408809
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.
Darius H; Hossmann V; Schrör K
Klin Wochenschr; 1986 Jun; 64(12):545-51. PubMed ID: 2426514
[TBL] [Abstract][Full Text] [Related]
11. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris.
Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S
Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664
[TBL] [Abstract][Full Text] [Related]
12. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ
Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095
[TBL] [Abstract][Full Text] [Related]
13. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of iloprost, a prostacyclin analog.
Kaukinen S; Ylitalo P; Pessi T; Vapaatalo H
Clin Pharmacol Ther; 1984 Oct; 36(4):464-9. PubMed ID: 6206978
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation with intravenous and oral administration of a carboprostacyclin analogue, 15-cyclopentyl-omega-pentanor-5(E)-carbacyclin (ONO 41483) in man.
Adaikan PG; Lau LC; Tai MY; Karim SM
Prostaglandins Leukot Med; 1983 Jan; 10(1):53-64. PubMed ID: 6338531
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and pharmacology of ciprostene, a stable epoprostenol (prostacyclin) analogue in humans.
Linet OI; Nishizawa EE; Schaub RG; VanderLugt JT; Greenwald CA
J Clin Pharmacol; 1986 Feb; 26(2):131-40. PubMed ID: 3005377
[TBL] [Abstract][Full Text] [Related]
17. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
Data JL; Molony BA; Meinzinger MM; Gorman RR
Circulation; 1981 Jul; 64(1):4-12. PubMed ID: 6263515
[TBL] [Abstract][Full Text] [Related]
18. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Visoná A; Lusiani L; Pagnan A
Clin Pharmacol Ther; 1988 Aug; 44(2):211-6. PubMed ID: 2456174
[TBL] [Abstract][Full Text] [Related]
19. Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374.
Yardumian DA; Mackie IJ; Bull H; Goldstone AH; Machin SJ
Br J Haematol; 1985 May; 60(1):109-16. PubMed ID: 2408653
[TBL] [Abstract][Full Text] [Related]
20. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
Wadenvik H; Kutti J
Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
